Skip to content

Comparison of two type of manual therapy techniques for shoulder in women affected with breast cancer.

COMPARATIVE STUDY OF MULLIGANâ??S MOBILIZATION WITH MOVEMENT VERSUS KALTENBORN MOBILIZATION ON SHOULDER IMPAIRMENT IN WOMEN OPERATED FOR BREAST CANCER â??A RANDOMIZED CONTROLLED TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030692
Enrollment
45
Registered
2021-01-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site Health Condition 2: null- operated cases of breast cancer

Interventions

Intervention1: Kaltenborn mobilization: Kaltenborn mobilization grade 1 and 2 for flexion and abduction. The treatment commenced on day 3 post operative and was given for seven sessions Control Interv

Sponsors

KLE University Institute of physiotherapy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Age 35-70years 2)Subjects who have undergone breast cancer surgery (breast-conservative surgeries,total mastectomy, radical mastectomy or modified radical mastectomy with or without axillary lymph node dissection and radiation therapy) 3)Pain and impaired shoulder mobility on the ipsilateral side 4)Shoulder flexion and abduction ROM

Exclusion criteria

Exclusion criteria: 1)Lumpectomy 2)Axillary web syndrome 3)Bone metastasis in the ipsilateral upper limb 4)Recent or unhealed fractures around the ipsilateral shoulder ( 5)Post-operative infection 6)Nerve injury during surgery

Design outcomes

Primary

MeasureTime frame
Pain, ROMTimepoint: at baseline and after 7 sessions

Secondary

MeasureTime frame
EORTC-QLQ-BR23 questionnaireTimepoint: at baseline and after 7 sessions

Countries

India

Contacts

Public ContactSanjiv Kumar

kle university institute of physiotherapy

anandhegs@yahoo.co.in08312473906

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026